The principal investigator notes that the recently discovered class of remarkably effective anti-HIV natural products known as the calanolides are extremely difficult to obtain from natural sources. He reports that in his Phase I work, he has completed the total synthesis of racemic calanolide A, the most potent of the compounds reported, using readily available starting materials. He states that during the Phase II research program, he plans to improve his synthetic methodology so as to prepare large quantities of calanolide A in an efficient and economical manner, and that he also intends to design and synthesize a number of selected analogs of calanolide A which may possess more potent anti-HIV activity, fewer side effects, and better drug delivery properties than the parent natural product.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI034805-02
Application #
2069986
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1993-08-15
Project End
1997-03-31
Budget Start
1995-04-10
Budget End
1996-03-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Medichem Research, Inc.
Department
Type
DUNS #
City
Lemont
State
IL
Country
United States
Zip Code
60439